Autonomic Technologies Receives $23,045,640 Series D Financing Round

  • Feed Type
  • Date
    6/8/2016
  • Company Name
    Autonomic Technologies
  • Mailing Address
    3698 Haven Ave. Redwood City, CA 94063 USA
  • Company Description
    Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.
  • Website
    http://www.autonomictechnologies.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,045,640
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 23 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy